1154758-73-2

Basic information

• Product Name: 6'-PNZ-3,3''-diBoc-1-(N-Boc-4-amino-2(S)-hydroxy-butyryl)-sisomicin
• Synonyms: 6'-PNZ-3,3''-diBoc-1-(N-Boc-4-amino-2(S)-hydroxy-butyryl)-sisomicin
• CAS NO: 1154758-73-2
• Molecular Weight: 1028.12
• Mol File: 1154758-73-2.mol

Chemical Properties

• CAS DataBase Reference: 6'-PNZ-3,3''-diBoc-1-(N-Boc-4-amino-2(S)-hydroxy-butyryl)-sisomicin(CAS DataBase Reference)
• NIST Chemistry Reference: 6'-PNZ-3,3''-diBoc-1-(N-Boc-4-amino-2(S)-hydroxy-butyryl)-sisomicin(1154758-73-2)
• EPA Substance Registry System: 6'-PNZ-3,3''-diBoc-1-(N-Boc-4-amino-2(S)-hydroxy-butyryl)-sisomicin(1154758-73-2)

Safety Data

• Hazardous Substances Data: 1154758-73-2(Hazardous Substances Data)

Upstream product

• 1235078-99-5 tert-butyl 2,4-dioxo-3-azabicyclo[3.2.1]oct-6-en-3-yl carbonate 
• 1154758-69-6 6',2'-diPNZ-3-Boc-sisomicin 
• 1154758-64-1 6',2'-diPNZ-sisomicin 
• 24424-99-5 di-tert-butyl dicarbonate 
• 32385-11-8 sisomicin 
• 1154758-31-2 N-(4-nitrobenzyl carbonate)bicyclo[2.2.1]hept-5-ene-2,3-dicarboxylic acid imide 
• 1154758-72-1 3,3''-diBoc-1-(N-Boc-4-amino-2(S)-hydroxy-butyryl)-sisomicin 
• 4457-32-3 4-nitrobenzyl chloroformate 
• 207305-60-0 (S)-4-[(tert-butoxycarbonyl)amino]-2-hydroxybutanoic acid 
• 53179-09-2 Sisomicin sulfate 
• 1154758-70-9 6',2'-diPNZ-3-Boc-1-(N-Boc-4-amino-2(S)-hydroxy-butyryl)-sisomicin 

Downstream Products

• 1154760-56-1 6'-PNZ-2'-(N-phthalimido-2-amino-ethylsulfonamide)-3,3''-diBoc-1-(N-Boc-4-amino-2(S)-hydroxy-butyryl)-sisomicin 
• 1154760-48-1 6'-PNZ-2'-(N-phthalimido-3-amino-propyl)-3,3''-diBoc-1-(N-Boc-4-amino-2(S)-hydroxy-butyryl)-sisomicin 
• 1154760-35-6 6'-PNZ-2'-(N-Boc-N-methyl-amino-acetyl)-3,3''-diBoc-1-(N-Boc-4-amino-2(S)-hydroxy-butyryl)-sisomicin 

Relevant articles and documents

TREATMENT OF URINARY TRACT INFECTIONS WITH ANTIBACTERIAL AMINOGLYCOSIDE COMPOUNDS

A method for treating a urinary tract infection in a mammal in need thereof is disclosed, the method comprising administering to the mammal an effective amount of an antibacterial aminoglycoside compound.

ANTIBACTERIAL AMINOGLYCOSIDE ANALOGS

Compounds of structure (I): having antibacterial activity are disclosed, including stereoisomers, pharmaceutically acceptable salts and prodrugs thereof, wherein Q1, Q2, Q3, R8 and R9 are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.